Loading company…
Traversa Therapeutics develops RNAi delivery technologies and related therapeutics.
Founded in 2006, Traversa Therapeutics is a biopharmaceutical company engaged in the discovery, development, and commercialization of RNAi delivery technologies.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in